Over the past year, KNBIF returned -19.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -17.7% |
| 1 year | -19.8% |
| 5 years | -83.1% |
| 10 years | -85.2% |
| All-time high | $1.92 (Aug 2007) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in KNBIF would be worth today ›No. Kane Biotech Inc. has not paid a dividend in the past 12 months.
Kane Biotech Inc. is part of the Healthcare sector.
Kane Biotech Inc. has a market cap of 4.49M USD, based on the latest quote.
Kane Biotech Inc. is expected to report earnings around Aug 27, 2026. That date is an estimate and has not been confirmed by the company.
